Vergoeding 2014-2018 voor ATC-subgroep L04AA : Selectieve immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| L04AA06 Mycofenolzuur (Cellcept ®) | 10.237.800 | 10.651.700 | 10.997.600 | 11.032.600 | 10.930.200 |
| L04AA10 Sirolimus (Rapamune ®) | 1.529.700 | 1.532.400 | 1.520.200 | 1.454.900 | 1.439.700 |
| L04AA13 Leflunomide (Arava ®) | 2.339.300 | 2.269.500 | 1.995.400 | 1.924.700 | 2.041.800 |
| L04AA18 Everolimus (Certican ®) | 2.639.000 | 3.143.800 | 4.051.000 | 4.252.200 | 4.881.400 |
| L04AA27 Fingolimod (Gilenya ®) | 18.239.400 | 21.522.300 | 22.922.700 | 24.383.400 | 27.108.300 |
| L04AA31 Teriflunomide (Aubagio ®) | 1.019.100 | 4.810.200 | 8.508.200 | 10.978.200 | 12.734.400 |
| Totaal | 36.004.300 | 43.929.900 | 49.995.100 | 54.026.000 | 59.135.800 |